160707,1,Admission,O
160707,1,Date,O
160707,1,:,O
160707,1,[,O
160707,1,**2165-6-3**,O
160707,1,],O
160707,1,Discharge,O
160707,1,Date,O
160707,1,:,O
160707,1,[,O
160707,1,**2165-6-24**,O
160707,1,],O
160707,1,Date,O
160707,1,of,O
160707,1,Birth,O
160707,1,:,O
160707,1,[,O
160707,1,**2098-4-23**,O
160707,1,],O
160707,1,Sex,O
160707,1,:,O
160707,1,M,O
160707,1,Service,O
160707,1,:,O
160707,1,MEDICINE,O
160707,1,Allergies,O
160707,1,:,O
160707,1,Ampicillin,B-Drug
160707,1,/,O
160707,1,peanuts,O
160707,1,Attending,O
160707,1,:,O
160707,1,[,O
160707,1,**First,O
160707,1,Name3,O
160707,1,(,O
160707,1,LF,O
160707,1,),O
160707,1,2297**,O
160707,1,],O
160707,1,Chief,O
160707,1,Complaint,O
160707,1,:,O
160707,1,MUD,O
160707,1,AlloHSCT,O
160707,1,Major,O
160707,1,Surgical,O
160707,1,or,O
160707,1,Invasive,O
160707,1,Procedure,O
160707,1,:,O
160707,1,-,O
160707,1,MUD,O
160707,1,AlloHSCT,O
160707,1,-,O
160707,1,VP,O
160707,1,shunt,O
160707,1,tap,O
160707,1,-,O
160707,1,Bronchoscopy,O
160707,1,History,O
160707,1,of,O
160707,1,Present,O
160707,1,Illness,O
160707,1,:,O
160707,1,Mr.,O
160707,1,[,O
160707,1,**Known,O
160707,1,lastname,O
160707,1,**,O
160707,1,],O
160707,1,is,O
160707,1,a,O
160707,1,67-year-old,O
160707,1,man,O
160707,1,with,O
160707,1,trasnufsion,O
160707,1,dependent,O
160707,1,myelodysplastic,O
160707,1,disorder,O
160707,1,",",O
160707,1,normal,O
160707,1,pressure,O
160707,1,hydrocephalus,O
160707,1,",",O
160707,1,DM,O
160707,1,",",O
160707,1,CAD,O
160707,1,",",O
160707,1,HTN,O
160707,1,who,O
160707,1,is,O
160707,1,electively,O
160707,1,admitted,O
160707,1,for,O
160707,1,Allo,O
160707,1,SCT,B-Drug
160707,1,.,O
160707,1,.,O
160707,1,He,O
160707,1,was,O
160707,1,last,O
160707,1,seen,O
160707,1,in,O
160707,1,clinic,O
160707,1,[,O
160707,1,**5-30**,O
160707,1,],O
160707,1,w,O
160707,1,Dr.,O
160707,1,[,O
160707,1,**Last,O
160707,1,Name,O
160707,1,(,O
160707,1,STitle,O
160707,1,),O
160707,1,410**,O
160707,1,],O
160707,1,for,O
160707,1,preadmission,O
160707,1,testing,O
160707,1,prior,O
160707,1,to,O
160707,1,planned,O
160707,1,admission,O
160707,1,today,O
160707,1,for,O
160707,1,a,O
160707,1,non-myeloablative,O
160707,1,matched,O
160707,1,unrelated,O
160707,1,donor,O
160707,1,transplant,O
160707,1,for,O
160707,1,his,O
160707,1,MDS,O
160707,1,that,O
160707,1,is,O
160707,1,associated,O
160707,1,with,O
160707,1,pancytopenia,O
160707,1,and,O
160707,1,transfusion,O
160707,1,dependence,O
160707,1,of,O
160707,1,both,O
160707,1,red,B-Drug
160707,1,cells,I-Drug
160707,1,and,O
160707,1,platelets,B-Drug
160707,1,.,O
160707,1,Last,O
160707,1,transfusion,O
160707,1,[,O
160707,1,**5-28**,O
160707,1,],O
160707,1,.,O
160707,1,Due,O
160707,1,to,O
160707,1,multiple,O
160707,1,transfusions,O
160707,1,",",O
160707,1,he,O
160707,1,has,O
160707,1,develoepd,O
160707,1,Fe,O
160707,1,overload,O
160707,1,",",O
160707,1,and,O
160707,1,has,O
160707,1,been,O
160707,1,on,O
160707,1,chelation,B-Reason
160707,1,therapy,I-Reason
160707,1,with,O
160707,1,deferasirox,B-Drug
160707,1,.,I-Drug
160707,1,He,O
160707,1,is,O
160707,1,admitted,O
160707,1,for,O
160707,1,protocol,O
160707,1,driven,O
160707,1,reduced,O
160707,1,intensity,O
160707,1,MUD,O
160707,1,allo,O
160707,1,.,O
160707,1,The,O
160707,1,conditioning,O
160707,1,is,O
160707,1,to,O
160707,1,inlcude,O
160707,1,clofarabine,B-Drug
160707,1,",",I-Drug
160707,1,total,O
160707,1,nodal,O
160707,1,radiation,O
160707,1,and,O
160707,1,ATG,B-Drug
160707,1,.,O
160707,1,The,O
160707,1,donor,O
160707,1,match,O
160707,1,is,O
160707,1,9/10,O
160707,1,per,O
160707,1,Dr.,O
160707,1,[,O
160707,1,**First,O
160707,1,Name8,O
160707,1,(,O
160707,1,NamePattern2,O
160707,1,),O
160707,1,**,O
160707,1,],O
160707,1,[,O
160707,1,**Last,O
160707,1,Name,O
160707,1,(,O
160707,1,NamePattern1,O
160707,1,),O
160707,1,**,O
160707,1,],O
160707,1,progress,O
160707,1,note,O
160707,1,.,O
160707,1,.,O
160707,1,Per,O
160707,1,Dr.,O
160707,1,[,O
160707,1,**Name,O
160707,1,(,O
160707,1,NI,O
160707,1,),O
160707,1,3588**,O
160707,1,],O
160707,1,clinic,O
160707,1,evaluation,O
160707,1,on,O
160707,1,[,O
160707,1,**5-23**,O
160707,1,],O
160707,1,this,O
160707,1,pt,O
160707,1,has,O
160707,1,an,O
160707,1,absolute,O
160707,1,neutropenia,O
160707,1,.,O
160707,1,[,O
160707,1,**10/2164**,O
160707,1,],O
160707,1,he,O
160707,1,was,O
160707,1,admitted,O
160707,1,to,O
160707,1,the,O
160707,1,ICU,O
160707,1,with,O
160707,1,CAP/neutropenic,B-Reason
160707,1,fevers,I-Reason
160707,1,based,O
160707,1,upon,O
160707,1,chest,O
160707,1,imaging,O
160707,1,findings,O
160707,1,and,O
160707,1,ROS,O
160707,1,.,O
160707,1,He,O
160707,1,was,O
160707,1,treated,O
160707,1,with,O
160707,1,vancomycin,B-Drug
160707,1,",",O
160707,1,cefepime,B-Drug
160707,1,and,O
160707,1,ciprofloxacin,B-Drug
160707,1,",",O
160707,1,no,O
160707,1,pathogen,O
160707,1,was,O
160707,1,isolated,O
160707,1,.,O
160707,1,During,O
160707,1,that,O
160707,1,hospitalization,O
160707,1,",",O
160707,1,he,O
160707,1,was,O
160707,1,diagnosed,O
160707,1,with,O
160707,1,HSV,O
160707,1,1,O
160707,1,outbreak,O
160707,1,on,O
160707,1,his,O
160707,1,neck,O
160707,1,(,O
160707,2,no,O
160707,2,lesions,O
160707,2,in,O
160707,2,his,O
160707,2,mouth,O
160707,2,or,O
160707,2,periorally,O
160707,2,),O
160707,2,",",O
160707,2,and,O
160707,2,was,O
160707,2,also,O
160707,2,diagnosed,O
160707,2,with,O
160707,2,insulin,O
160707,2,dependent,O
160707,2,DM-2,O
160707,2,.,O
160707,2,.,O
160707,2,On,O
160707,2,the,O
160707,2,floor,O
160707,2,",",O
160707,2,he,O
160707,2,complains,O
160707,2,of,O
160707,2,ongoing,O
160707,2,seasonal,O
160707,2,allergies,O
160707,2,with,O
160707,2,dry,O
160707,2,dcough,O
160707,2,and,O
160707,2,watery,O
160707,2,eyes,O
160707,2,.,O
160707,2,Cough,O
160707,2,is,O
160707,2,non-productive,O
160707,2,.,O
160707,2,He,O
160707,2,has,O
160707,2,not,O
160707,2,noted,O
160707,2,any,O
160707,2,fevers,O
160707,2,at,O
160707,2,home,O
160707,2,.,O
160707,2,Denies,O
160707,2,dyspnea,O
160707,2,on,O
160707,2,exertion,O
160707,2,",",O
160707,2,shortness,O
160707,2,of,O
160707,2,breath,O
160707,2,",",O
160707,2,PND,O
160707,2,",",O
160707,2,or,O
160707,2,orthopnea,O
160707,2,.,O
160707,2,He,O
160707,2,has,O
160707,2,no,O
160707,2,sore,O
160707,2,throat,O
160707,2,or,O
160707,2,ear,O
160707,2,pain,O
160707,2,.,O
160707,2,He,O
160707,2,has,O
160707,2,had,O
160707,2,one,O
160707,2,episode,O
160707,2,of,O
160707,2,diarrhea,O
160707,2,in,O
160707,2,the,O
160707,2,last,O
160707,2,day,O
160707,2,which,O
160707,2,is,O
160707,2,typical,O
160707,2,following,O
160707,2,Exgade,B-Drug
160707,2,.,O
160707,2,Past,O
160707,2,Medical,O
160707,2,History,O
160707,2,:,O
160707,2,Past,O
160707,2,Medical,O
160707,2,History,O
160707,2,:,O
160707,2,-CAD,O
160707,2,",",O
160707,2,s/p,O
160707,2,ant,O
160707,2,MI,O
160707,2,[,O
160707,2,**2139**,O
160707,2,],O
160707,2,",",O
160707,2,with,O
160707,2,hx,O
160707,2,LCX,O
160707,2,",",O
160707,2,LAD,O
160707,2,and,O
160707,2,RCA,O
160707,2,stenosis,O
160707,2,seen,O
160707,2,on,O
160707,2,cardiac,O
160707,2,CT,O
160707,2,2/,O
160707,2,[,O
160707,2,**2164**,O
160707,2,],O
160707,2,.,O
160707,2,Never,O
160707,2,had,O
160707,2,stents,O
160707,2,or,O
160707,2,angioplasty,O
160707,2,.,O
160707,2,-,O
160707,2,[,O
160707,2,**4-/2165**,O
160707,2,],O
160707,2,EF,O
160707,2,55,O
160707,2,%,O
160707,2,;,O
160707,2,cardiology,O
160707,2,cleared,O
160707,2,for,O
160707,2,transplant,O
160707,2,-,O
160707,2,Angina,B-Reason
160707,2,-,O
160707,2,once,O
160707,2,weekly,O
160707,2,depending,O
160707,2,on,O
160707,2,anemia,O
160707,2,and,O
160707,2,stress,O
160707,2,levels,O
160707,2,normally,O
160707,2,lasting,O
160707,2,10-15,O
160707,2,mins,O
160707,2,and,O
160707,2,resolves,O
160707,2,with,O
160707,2,nitro,B-Drug
160707,2,.,O
160707,2,Describes,O
160707,2,as,O
160707,2,a,O
160707,2,squeezing,O
160707,2,central/left,O
160707,2,chest,O
160707,2,pain,O
160707,2,with,O
160707,2,no,O
160707,2,radiation,O
160707,2,usually,O
160707,2,but,O
160707,2,can,O
160707,2,rarely,O
160707,2,will,O
160707,2,rarely,O
160707,2,feel,O
160707,2,in,O
160707,2,these,O
160707,2,locations,O
160707,2,.,O
160707,2,No,O
160707,2,nausea/vomiting,O
160707,2,or,O
160707,2,sweating,O
160707,2,.,O
160707,2,-NPH,O
160707,2,:,O
160707,2,s/p,O
160707,2,VP,O
160707,2,shunt,O
160707,2,placement,O
160707,2,[,O
160707,2,**11/2164**,O
160707,2,],O
160707,2,w,O
160707,2,resolution,O
160707,2,of,O
160707,2,sx,O
160707,2,-PVD,O
160707,2,-Diabetes,O
160707,2,Mellitus,O
160707,2,-,O
160707,2,BPH,B-Reason
160707,2,on,O
160707,2,flomax,B-Drug
160707,2,-OSA,O
160707,2,on,O
160707,2,CPAP,O
160707,2,with,O
160707,2,morbid,O
160707,2,obesity,O
160707,2,-History,O
160707,2,of,O
160707,2,possible,O
160707,2,TIA,O
160707,2,[,O
160707,2,**2162**,O
160707,2,],O
160707,2,?,O
160707,2,CVA,O
160707,2,-,O
160707,2,had,O
160707,2,resolution,O
160707,2,of,O
160707,2,eye,O
160707,2,position,O
160707,2,-abnormalities,O
160707,2,over,O
160707,2,a,O
160707,2,few,O
160707,2,days,O
160707,2,-Hypertension,O
160707,2,-Hypercholesterolemia,O
160707,2,-Asthma,O
160707,2,",",O
160707,2,cold-induced,O
160707,2,",",O
160707,2,not,O
160707,2,using,O
160707,2,inhalers,O
160707,2,at,O
160707,2,home,O
160707,2,-s/p,O
160707,2,ruptured,O
160707,2,appendix,O
160707,2,20yrs,O
160707,2,ago,O
160707,2,-s/p,O
160707,2,right,O
160707,2,carotid,O
160707,2,endarterectomy,O
160707,2,several,O
160707,2,years,O
160707,2,ago,O
160707,2,-HSV-1,O
160707,2,[,O
160707,2,**10/2165**,O
160707,2,],O
160707,2,.,O
160707,2,Hematologic,O
160707,2,Hx,O
160707,2,Longstanding,O
160707,2,history,O
160707,2,of,O
160707,2,myelodysplastic,O
160707,2,disorder,O
160707,2,associated,O
160707,2,with,O
160707,2,severe,O
160707,2,pancytopenia,B-Reason
160707,2,",",O
160707,2,now,O
160707,2,red,B-Drug
160707,2,cell,I-Drug
160707,2,and,O
160707,2,platelet,B-Drug
160707,2,transfusion,O
160707,2,requiring,O
160707,2,.,O
160707,2,Initially,O
160707,2,diagnosed,O
160707,2,[,O
160707,2,**2160-1-30**,O
160707,2,],O
160707,2,when,O
160707,2,his,O
160707,2,primary,O
160707,2,care,O
160707,2,physician,O
160707,2,",",O
160707,2,[,O
160707,2,**Last,O
160707,2,Name,O
160707,2,(,O
160707,2,NamePattern4,O
160707,2,),O
160707,2,**,O
160707,2,],O
160707,3,.,O
160707,3,[,O
160707,3,**First,O
160707,3,Name4,O
160707,3,(,O
160707,3,NamePattern1,O
160707,3,),O
160707,3,**,O
160707,3,],O
160707,3,[,O
160707,3,**Last,O
160707,3,Name,O
160707,3,(,O
160707,3,NamePattern1,O
160707,3,),O
160707,3,**,O
160707,3,],O
160707,3,",",O
160707,3,obtained,O
160707,3,a,O
160707,3,complete,O
160707,3,blood,O
160707,3,countas,O
160707,3,a,O
160707,3,part,O
160707,3,of,O
160707,3,routine,O
160707,3,maintenance,O
160707,3,physical,O
160707,3,examination,O
160707,3,.,O
160707,3,At,O
160707,3,that,O
160707,3,time,O
160707,3,he,O
160707,3,had,O
160707,3,anemia,O
160707,3,",",O
160707,3,a,O
160707,3,low,O
160707,3,platelet,O
160707,3,count,O
160707,3,",",O
160707,3,and,O
160707,3,a,O
160707,3,borderline,O
160707,3,low,O
160707,3,white,O
160707,3,blood,O
160707,3,count,O
160707,3,.,O
160707,3,He,O
160707,3,was,O
160707,3,treated,O
160707,3,briefly,O
160707,3,with,O
160707,3,azacitidine,B-Drug
160707,3,(,I-Drug
160707,3,Vidaza,I-Drug
160707,3,),I-Drug
160707,3,with,O
160707,3,4,O
160707,3,cycles,O
160707,3,in,O
160707,3,[,O
160707,3,**State,O
160707,3,108**,O
160707,3,],O
160707,3,but,O
160707,3,his,O
160707,3,disease,O
160707,3,did,O
160707,3,not,O
160707,3,stabilize,O
160707,3,.,O
160707,3,He,O
160707,3,has,O
160707,3,been,O
160707,3,getting,O
160707,3,PRBC,B-Drug
160707,3,'s,I-Drug
160707,3,and,O
160707,3,platelet,B-Drug
160707,3,tranfusions,O
160707,3,",",O
160707,3,as,O
160707,3,well,O
160707,3,as,O
160707,3,iron,B-Reason
160707,3,chelation,I-Reason
160707,3,with,O
160707,3,deferasirox,B-Drug
160707,3,(,I-Drug
160707,3,Exjade,I-Drug
160707,3,),I-Drug
160707,3,.,O
160707,3,Social,O
160707,3,History,O
160707,3,:,O
160707,3,Lives,O
160707,3,with,O
160707,3,wife,O
160707,3,in,O
160707,3,house,O
160707,3,with,O
160707,3,13,O
160707,3,stairs,O
160707,3,Able,O
160707,3,to,O
160707,3,walk,O
160707,3,to,O
160707,3,the,O
160707,3,car,O
160707,3,and,O
160707,3,can,O
160707,3,walk,O
160707,3,[,O
160707,3,**12-30**,O
160707,3,],O
160707,3,block,O
160707,3,limited,O
160707,3,withlow,O
160707,3,back,O
160707,3,pain,O
160707,3,.,O
160707,3,He,O
160707,3,previously,O
160707,3,worked,O
160707,3,as,O
160707,3,a,O
160707,3,computer,O
160707,3,programmer,O
160707,3,and,O
160707,3,retired,O
160707,3,.,O
160707,3,Ex-smoker,O
160707,3,quit,O
160707,3,20,O
160707,3,years,O
160707,3,ago,O
160707,3,previously,O
160707,3,3,O
160707,3,packs,O
160707,3,per,O
160707,3,day,O
160707,3,for,O
160707,3,25,O
160707,3,years,O
160707,3,.,O
160707,3,Alcohol,O
160707,3,-he,O
160707,3,has,O
160707,3,not,O
160707,3,had,O
160707,3,any,O
160707,3,ETOH,O
160707,3,in,O
160707,3,2,O
160707,3,weeks,O
160707,3,",",O
160707,3,typically,O
160707,3,drinks,O
160707,3,2,O
160707,3,drinks,O
160707,3,per,O
160707,3,week,O
160707,3,.,O
160707,3,He,O
160707,3,does,O
160707,3,not,O
160707,3,use,O
160707,3,illicit,O
160707,3,drugs,O
160707,3,No,O
160707,3,recent,O
160707,3,foreign,O
160707,3,travel,O
160707,3,Pets,O
160707,3,-,O
160707,3,1,O
160707,3,dog,O
160707,3,and,O
160707,3,2,O
160707,3,cats,O
160707,3,Family,O
160707,3,History,O
160707,3,:,O
160707,3,Father,O
160707,3,died,O
160707,3,of,O
160707,3,melanoma,O
160707,3,Mother,O
160707,3,died,O
160707,3,of,O
160707,3,coronary,O
160707,3,artery,O
160707,3,disease,O
160707,3,",",O
160707,3,and,O
160707,3,hypercholesterolemia,O
160707,3,also,O
160707,3,had,O
160707,3,a,O
160707,3,AAA,O
160707,3,repair,O
160707,3,Sister,O
160707,3,who,O
160707,3,had,O
160707,3,coronary,O
160707,3,artery,O
160707,3,disease,O
160707,3,and,O
160707,3,underwent,O
160707,3,a,O
160707,3,4-vessel,O
160707,3,CABG,O
160707,3,.,O
160707,3,Daughter,O
160707,3,is,O
160707,3,alive,O
160707,3,and,O
160707,3,healthy,O
160707,3,.,O
160707,3,Physical,O
160707,3,Exam,O
160707,3,:,O
160707,3,Vitals,O
160707,3,:,O
160707,3,T98.5,O
160707,3,BP110/58,O
160707,3,P:60,O
160707,3,RR:18,O
160707,3,Sa02,O
160707,3,99RA,O
160707,3,General,O
160707,3,:,O
160707,3,caucasian,O
160707,3,male,O
160707,3,appering,O
160707,3,comfortable,O
160707,3,and,O
160707,3,in,O
160707,3,NAD,O
160707,3,HEENT,O
160707,3,:,O
160707,3,Right,O
160707,3,sided,O
160707,3,VP,O
160707,3,shunt,O
160707,3,in,O
160707,3,place,O
160707,3,.,O
160707,3,Sclera,O
160707,3,anicteric,O
160707,3,",",O
160707,3,MMM,O
160707,3,",",O
160707,3,two,O
160707,3,small,O
160707,3,areas,O
160707,3,of,O
160707,3,petichae,O
160707,3,on,O
160707,3,left,O
160707,3,buccal,O
160707,3,mucosa,O
160707,3,Neck,O
160707,3,:,O
160707,3,Well,O
160707,3,healed,O
160707,3,right,O
160707,3,CEA,O
160707,3,scar,O
160707,3,.,O
160707,3,Supple,O
160707,3,",",O
160707,3,no,O
160707,3,LAD,O
160707,3,.,O
160707,3,Lungs,O
160707,3,:,O
160707,3,CTABL,O
160707,3,",",O
160707,3,no,O
160707,3,wheezes,O
160707,3,",",O
160707,3,no,O
160707,3,rales,O
160707,3,or,O
160707,3,ronchi,O
160707,3,CV,O
160707,3,:,O
160707,3,Regular,O
160707,3,rhythm,O
160707,3,",",O
160707,3,normal,O
160707,3,S1,O
160707,3,+,O
160707,3,S2,O
160707,3,",",O
160707,4,no,O
160707,4,MRG,O
160707,4,Abdomen,O
160707,4,:,O
160707,4,Midline,O
160707,4,abdominal,O
160707,4,scar,O
160707,4,well,O
160707,4,healed,O
160707,4,.,O
160707,4,bowel,O
160707,4,sounds,O
160707,4,normoactive,O
160707,4,no,O
160707,4,guarding,O
160707,4,",",O
160707,4,no,O
160707,4,rebound,O
160707,4,Ext,O
160707,4,:,O
160707,4,L,O
160707,4,>,O
160707,4,R,O
160707,4,lower,O
160707,4,extremity,O
160707,4,edema,O
160707,4,to,O
160707,4,mid,O
160707,4,calf,O
160707,4,.,O
160707,4,CN,O
160707,4,exam,O
160707,4,-,O
160707,4,II-XII,O
160707,4,normal,O
160707,4,",",O
160707,4,normal,O
160707,4,cerebellar,O
160707,4,function,O
160707,4,with,O
160707,4,FTS,O
160707,4,and,O
160707,4,HTS,O
160707,4,intact,O
160707,4,.,O
160707,4,Pertinent,O
160707,4,Results,O
160707,4,:,O
160707,4,ADMISSION,O
160707,4,LABS,O
160707,4,===============,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,WBC-1.3*,O
160707,4,RBC-2.90*,O
160707,4,Hgb-8.9*,O
160707,4,Hct-23.9*,O
160707,4,MCV-82,O
160707,4,MCH-30.6,O
160707,4,MCHC-37.3*,O
160707,4,RDW-13.1,O
160707,4,Plt,O
160707,4,Ct-24*,O
160707,4,#,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,Neuts-15*,O
160707,4,Bands-0,O
160707,4,Lymphs-75*,O
160707,4,Monos-7,O
160707,4,Eos-0,O
160707,4,Baso-0,O
160707,4,Atyps-3*,O
160707,4,Metas-0,O
160707,4,Myelos-0,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,PT-12.0,O
160707,4,PTT-25.4,O
160707,4,INR,O
160707,4,(,O
160707,4,PT,O
160707,4,),O
160707,4,-1.0,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,UreaN-23*,O
160707,4,Creat-1.1,O
160707,4,Na-139,O
160707,4,K-4.6,O
160707,4,Cl-103,O
160707,4,HCO3-27,O
160707,4,AnGap-14,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,ALT-23,O
160707,4,AST-18,O
160707,4,LD,O
160707,4,(,O
160707,4,LDH,O
160707,4,),O
160707,4,-131,O
160707,4,AlkPhos-86,O
160707,4,TotBili-0.8,O
160707,4,DirBili-0.2,O
160707,4,IndBili-0.6,O
160707,4,[,O
160707,4,**2165-6-3**,O
160707,4,],O
160707,4,09:05AM,O
160707,4,BLOOD,O
160707,4,TotProt-7.2,O
160707,4,Albumin-4.8,O
160707,4,Globuln-2.4,O
160707,4,Calcium-10.3,O
160707,4,Phos-3.8,O
160707,4,Mg-2.2,O
160707,4,UricAcd-4.7,O
160707,4,MICRO,O
160707,4,=====,O
160707,4,-,O
160707,4,Multiple,O
160707,4,blood,O
160707,4,cultures,O
160707,4,(,O
160707,4,including,O
160707,4,mycolytic,O
160707,4,),O
160707,4,and,O
160707,4,BAL,O
160707,4,cultures,O
160707,4,pending,O
160707,4,at,O
160707,4,the,O
160707,4,time,O
160707,4,of,O
160707,4,death,O
160707,4,.,O
160707,4,IMAGES,O
160707,4,======,O
160707,4,Head,O
160707,4,CT,O
160707,4,[,O
160707,4,**2165-6-13**,O
160707,4,],O
160707,4,NON-CONTRAST,O
160707,4,HEAD,O
160707,4,CT,O
160707,4,:,O
160707,4,There,O
160707,4,is,O
160707,4,no,O
160707,4,intracranial,O
160707,4,hemorrhage,O
160707,4,",",O
160707,4,parenchymal,O
160707,4,edema,O
160707,4,",",O
160707,4,or,O
160707,4,mass,O
160707,4,effect,O
160707,4,.,O
160707,4,A,O
160707,4,right,O
160707,4,frontal,O
160707,4,approach,O
160707,4,ventriculoperitoneal,O
160707,4,shunt,O
160707,4,catheter,O
160707,4,is,O
160707,4,again,O
160707,4,identified,O
160707,4,",",O
160707,4,in,O
160707,4,unchanged,O
160707,4,position,O
160707,4,",",O
160707,4,with,O
160707,4,tip,O
160707,4,traversing,O
160707,4,the,O
160707,4,septum,O
160707,4,pellucidum,O
160707,4,and,O
160707,4,terminating,O
160707,4,in,O
160707,4,the,O
160707,4,left,O
160707,4,lateral,O
160707,4,ventricle,O
160707,4,.,O
160707,4,The,O
160707,4,ventricles,O
160707,4,are,O
160707,4,again,O
160707,4,symmetrically,O
160707,4,prominent,O
160707,4,",",O
160707,4,not,O
160707,4,changed,O
160707,4,in,O
160707,4,size,O
160707,4,from,O
160707,4,prior,O
160707,4,studies,O
160707,4,.,O
160707,4,There,O
160707,4,is,O
160707,4,no,O
160707,4,shift,O
160707,4,of,O
160707,4,midline,O
160707,4,structures,O
160707,4,",",O
160707,4,and,O
160707,4,there,O
160707,4,is,O
160707,4,no,O
160707,4,effacement,O
160707,4,of,O
160707,4,the,O
160707,4,basal,O
160707,4,cisterns,O
160707,4,.,O
160707,4,There,O
160707,4,is,O
160707,4,no,O
160707,4,CT,O
160707,4,evidence,O
160707,4,of,O
160707,4,territorial,O
160707,4,infarct,O
160707,4,.,O
160707,4,Osseous,O
160707,4,structures,O
160707,4,remain,O
160707,4,unremarkable,O
160707,4,",",O
160707,4,and,O
160707,4,the,O
160707,4,visualized,O
160707,4,paranasal,O
160707,4,sinuses,O
160707,4,and,O
160707,4,mastoids,O
160707,4,are,O
160707,4,clear,O
160707,4,.,O
160707,4,Cavernous,O
160707,4,carotid,O
160707,4,calcifications,O
160707,4,are,O
160707,4,noted,O
160707,4,.,O
160707,4,.,O
160707,4,Renal,O
160707,4,Ultrasound,O
160707,4,[,O
160707,4,**2165-6-13**,O
160707,4,],O
160707,4,No,O
160707,4,hydronephrosis,O
160707,4,or,O
160707,4,other,O
160707,4,findings,O
160707,4,to,O
160707,4,explain,O
160707,4,acute,O
160707,4,renal,O
160707,4,failure,O
160707,4,.,O
160707,4,.,O
160707,4,CT,O
160707,4,chest,O
160707,4,[,O
160707,4,**2165-6-16**,O
160707,4,],O
160707,4,1,O
160707,4,.,O
160707,4,Multifocal,O
160707,4,pneumonia,O
160707,4,which,O
160707,4,may,O
160707,4,be,O
160707,4,bacterial,O
160707,5,or,O
160707,5,fungal,O
160707,5,",",O
160707,5,with,O
160707,5,vasculitis,O
160707,5,a,O
160707,5,less,O
160707,5,likely,O
160707,5,consideration,O
160707,5,.,O
160707,5,2,O
160707,5,.,O
160707,5,Left,O
160707,5,adrenal,O
160707,5,nodule,O
160707,5,",",O
160707,5,stable,O
160707,5,compared,O
160707,5,with,O
160707,5,10/10,O
160707,5,.,O
160707,5,3,O
160707,5,.,O
160707,5,Right,O
160707,5,renal,O
160707,5,stone,O
160707,5,",",O
160707,5,uncomplicated,O
160707,5,.,O
160707,5,4,O
160707,5,.,O
160707,5,Diverticulosis,O
160707,5,.,O
160707,5,.,O
160707,5,Abdominal,O
160707,5,ultrasound,O
160707,5,[,O
160707,5,**2165-6-18**,O
160707,5,],O
160707,5,1,O
160707,5,.,O
160707,5,Normal,O
160707,5,abdominal,O
160707,5,ultrasound,O
160707,5,without,O
160707,5,gallbladder,O
160707,5,or,O
160707,5,biliary,O
160707,5,pathology,O
160707,5,.,O
160707,5,2,O
160707,5,.,O
160707,5,Echogenic,O
160707,5,focus,O
160707,5,in,O
160707,5,the,O
160707,5,interpolar,O
160707,5,region,O
160707,5,of,O
160707,5,right,O
160707,5,kidney,O
160707,5,likely,O
160707,5,represents,O
160707,5,milk,O
160707,5,of,O
160707,5,calcium,O
160707,5,though,O
160707,5,a,O
160707,5,nonobstructing,O
160707,5,renal,O
160707,5,calculi,O
160707,5,is,O
160707,5,a,O
160707,5,possibility,O
160707,5,.,O
160707,5,.,O
160707,5,MRI,O
160707,5,head,O
160707,5,w/o,O
160707,5,contrast,B-Drug
160707,5,[,O
160707,5,**2165-6-18**,O
160707,5,],O
160707,5,1,O
160707,5,.,O
160707,5,High,O
160707,5,signal,O
160707,5,on,O
160707,5,FLAIR,O
160707,5,images,O
160707,5,within,O
160707,5,the,O
160707,5,cerebral,O
160707,5,sulci,O
160707,5,may,O
160707,5,be,O
160707,5,secondary,O
160707,5,to,O
160707,5,recent,O
160707,5,lumbar,O
160707,5,puncture,O
160707,5,",",O
160707,5,although,O
160707,5,infectious,O
160707,5,leptomeningitis,O
160707,5,can,O
160707,5,not,O
160707,5,be,O
160707,5,excluded,O
160707,5,by,O
160707,5,imaging,O
160707,5,.,O
160707,5,High,O
160707,5,signal,O
160707,5,on,O
160707,5,FLAIR,O
160707,5,images,O
160707,5,within,O
160707,5,the,O
160707,5,dura,O
160707,5,may,O
160707,5,be,O
160707,5,related,O
160707,5,to,O
160707,5,the,O
160707,5,recent,O
160707,5,lumbar,O
160707,5,puncture,O
160707,5,or,O
160707,5,the,O
160707,5,VPS,O
160707,5,",",O
160707,5,but,O
160707,5,infectious,O
160707,5,pachymeningitis,O
160707,5,can,O
160707,5,not,O
160707,5,be,O
160707,5,excluded,O
160707,5,by,O
160707,5,imaging,O
160707,5,.,O
160707,5,Correlation,O
160707,5,with,O
160707,5,CSF,O
160707,5,analyses,O
160707,5,is,O
160707,5,recommended,O
160707,5,.,O
160707,5,2,O
160707,5,.,O
160707,5,No,O
160707,5,evidence,O
160707,5,for,O
160707,5,cerebritis,O
160707,5,or,O
160707,5,PRES,O
160707,5,.,O
160707,5,3,O
160707,5,.,O
160707,5,Stable,O
160707,5,moderate,O
160707,5,ventriculomegaly,O
160707,5,.,O
160707,5,Stable,O
160707,5,VPS,O
160707,5,tip,O
160707,5,position,O
160707,5,.,O
160707,5,4,O
160707,5,.,O
160707,5,Bilateral,O
160707,5,small,O
160707,5,superior,O
160707,5,parietal,O
160707,5,subdural,O
160707,5,collections,O
160707,5,",",O
160707,5,right,O
160707,5,greater,O
160707,5,than,O
160707,5,left,O
160707,5,",",O
160707,5,similar,O
160707,5,to,O
160707,5,[,O
160707,5,**2165-6-13**,O
160707,5,],O
160707,5,but,O
160707,5,new,O
160707,5,since,O
160707,5,[,O
160707,5,**2164-12-25**,O
160707,5,],O
160707,5,.,O
160707,5,They,O
160707,5,may,O
160707,5,represent,O
160707,5,hygromas,O
160707,5,secondary,O
160707,5,to,O
160707,5,the,O
160707,5,VPS,O
160707,5,.,O
160707,5,However,O
160707,5,",",O
160707,5,chronic,O
160707,5,subdural,O
160707,5,hematomas,O
160707,5,can,O
160707,5,not,O
160707,5,be,O
160707,5,excluded,O
160707,5,.,O
160707,5,.,O
160707,5,CT,O
160707,5,Torso,O
160707,5,[,O
160707,5,**2165-6-22**,O
160707,5,],O
160707,5,IMPRESSION,O
160707,5,:,O
160707,5,1,O
160707,5,.,O
160707,5,Coalescent,O
160707,5,consolidation,O
160707,5,of,O
160707,5,previous,O
160707,5,multifocal,O
160707,5,nodular,O
160707,5,opacities,O
160707,5,within,O
160707,5,the,O
160707,5,lungs,O
160707,5,.,O
160707,5,Innumerable,O
160707,5,bilateral,O
160707,5,submillimeter,O
160707,5,nodules,O
160707,5,with,O
160707,5,ground-glass,O
160707,5,attenuation,O
160707,5,distributed,O
160707,5,throughout,O
160707,5,both,O
160707,5,lungs,O
160707,5,with,O
160707,5,relative,O
160707,5,sparing,O
160707,5,of,O
160707,5,the,O
160707,5,periphery,O
160707,5,.,O
160707,5,Overall,O
160707,5,findings,O
160707,5,are,O
160707,5,concerning,O
160707,5,for,O
160707,5,semi-invasive,O
160707,5,pulmonary,O
160707,5,aspergillosis,O
160707,5,.,O
160707,5,No,O
160707,5,cavitation,O
160707,5,noted,O
160707,5,within,O
160707,5,these,O
160707,5,coalescent,O
160707,5,areas,O
160707,5,of,O
160707,5,consolidation,O
160707,5,.,O
160707,5,Findings,O
160707,5,in,O
160707,5,the,O
160707,5,chest,O
160707,5,have,O
160707,5,progressed,O
160707,5,significantly,O
160707,5,since,O
160707,5,prior,O
160707,5,imaging,O
160707,5,.,O
160707,5,2,O
160707,5,.,O
160707,5,Indeterminate,O
160707,5,left,O
160707,5,adrenal,O
160707,5,gland,O
160707,5,lesion,O
160707,5,.,O
160707,5,Further,O
160707,5,characterization,O
160707,5,with,O
160707,5,MR,O
160707,5,recommended,O
160707,5,.,O
160707,5,3,O
160707,5,.,O
160707,5,Non-obstructing,O
160707,6,4-mm,O
160707,6,right,O
160707,6,renal,O
160707,6,calculus,O
160707,6,.,O
160707,6,No,O
160707,6,intra-abdominal,O
160707,6,collection,O
160707,6,identified,O
160707,6,.,O
160707,6,Echo,O
160707,6,[,O
160707,6,**2165-6-23**,O
160707,6,],O
160707,6,Due,O
160707,6,to,O
160707,6,suboptimal,O
160707,6,technical,O
160707,6,quality,O
160707,6,",",O
160707,6,a,O
160707,6,focal,O
160707,6,wall,O
160707,6,motion,O
160707,6,abnormality,O
160707,6,can,O
160707,6,not,O
160707,6,be,O
160707,6,fully,O
160707,6,excluded,O
160707,6,.,O
160707,6,Overall,O
160707,6,left,O
160707,6,ventricular,O
160707,6,systolic,O
160707,6,function,O
160707,6,is,O
160707,6,severely,O
160707,6,depressed,O
160707,6,(,O
160707,6,LVEF=,O
160707,6,20-25,O
160707,6,%,O
160707,6,),O
160707,6,.,O
160707,6,The,O
160707,6,right,O
160707,6,ventricular,O
160707,6,cavity,O
160707,6,is,O
160707,6,moderately,O
160707,6,dilated,O
160707,6,with,O
160707,6,global,O
160707,6,free,O
160707,6,wall,O
160707,6,hypokinesis,O
160707,6,.,O
160707,6,Mild,O
160707,6,(,O
160707,6,1+,O
160707,6,),O
160707,6,mitral,O
160707,6,regurgitation,O
160707,6,is,O
160707,6,seen,O
160707,6,.,O
160707,6,There,O
160707,6,is,O
160707,6,a,O
160707,6,very,O
160707,6,small,O
160707,6,pericardial,O
160707,6,effusion,O
160707,6,.,O
160707,6,There,O
160707,6,is,O
160707,6,an,O
160707,6,anterior,O
160707,6,space,O
160707,6,which,O
160707,6,most,O
160707,6,likely,O
160707,6,represents,O
160707,6,a,O
160707,6,prominent,O
160707,6,fat,O
160707,6,pad,O
160707,6,.,O
160707,6,Compared,O
160707,6,to,O
160707,6,the,O
160707,6,findings,O
160707,6,of,O
160707,6,the,O
160707,6,prior,O
160707,6,study,O
160707,6,of,O
160707,6,[,O
160707,6,**2165-5-16**,O
160707,6,],O
160707,6,",",O
160707,6,left,O
160707,6,and,O
160707,6,right,O
160707,6,ventricular,O
160707,6,systolic,O
160707,6,function,O
160707,6,have,O
160707,6,deteriorated,O
160707,6,significantly,O
160707,6,.,O
160707,6,Brief,O
160707,6,Hospital,O
160707,6,Course,O
160707,6,:,O
160707,6,66,O
160707,6,year,O
160707,6,old,O
160707,6,M,O
160707,6,with,O
160707,6,transfusion,O
160707,6,dependent,O
160707,6,MDS,O
160707,6,",",O
160707,6,D+7,O
160707,6,s/p,O
160707,6,allo,O
160707,6,SCT,B-Drug
160707,6,",",O
160707,6,normal,O
160707,6,pressure,O
160707,6,hydrocephalus,O
160707,6,",",O
160707,6,CAD,O
160707,6,",",O
160707,6,HTN,O
160707,6,and,O
160707,6,diabetes,O
160707,6,",",O
160707,6,who,O
160707,6,was,O
160707,6,initially,O
160707,6,electively,O
160707,6,admitted,O
160707,6,for,O
160707,6,allo,O
160707,6,SCT,B-Drug
160707,6,with,O
160707,6,clofarabine,B-Drug
160707,6,",",O
160707,6,total,O
160707,6,nodal,O
160707,6,radiation,O
160707,6,and,O
160707,6,anti-thymoglobulin,O
160707,6,.,O
160707,6,His,O
160707,6,course,O
160707,6,was,O
160707,6,complicated,O
160707,6,by,O
160707,6,febrile,O
160707,6,neutropenia,O
160707,6,and,O
160707,6,renal,O
160707,6,failure,O
160707,6,.,O
160707,6,His,O
160707,6,creatinine,O
160707,6,was,O
160707,6,1.1,O
160707,6,on,O
160707,6,admission,O
160707,6,and,O
160707,6,rose,O
160707,6,to,O
160707,6,>,O
160707,6,5,O
160707,6,following,O
160707,6,administration,O
160707,6,of,O
160707,6,clofarabine,B-Drug
160707,6,per,O
160707,6,SCT,B-Drug
160707,6,protocol,O
160707,6,.,O
160707,6,He,O
160707,6,developed,O
160707,6,metabolic,O
160707,6,acidosis,O
160707,6,and,O
160707,6,worsening,O
160707,6,confusion,O
160707,6,over,O
160707,6,the,O
160707,6,course,O
160707,6,of,O
160707,6,several,O
160707,6,days,O
160707,6,leading,O
160707,6,up,O
160707,6,to,O
160707,6,his,O
160707,6,transplant,O
160707,6,.,O
160707,6,On,O
160707,6,SCT,B-Drug
160707,6,day,O
160707,6,+1,O
160707,6,",",O
160707,6,he,O
160707,6,was,O
160707,6,febrile,B-Reason
160707,6,and,O
160707,6,started,O
160707,6,on,O
160707,6,vancomycin,B-Drug
160707,6,and,O
160707,6,cefepime,B-Drug
160707,6,.,O
160707,6,On,O
160707,6,SCT,B-Drug
160707,6,day,O
160707,6,+3,O
160707,6,",",O
160707,6,he,O
160707,6,was,O
160707,6,transferred,O
160707,6,to,O
160707,6,ICU,O
160707,6,for,O
160707,6,worsening,O
160707,6,mental,O
160707,6,status,O
160707,6,",",O
160707,6,increased,O
160707,6,respiratory,O
160707,6,distress,O
160707,6,",",O
160707,6,and,O
160707,6,renal,O
160707,6,failure,O
160707,6,.,O
160707,6,He,O
160707,6,remained,O
160707,6,febrile,B-Reason
160707,6,and,O
160707,6,was,O
160707,6,seen,O
160707,6,by,O
160707,6,the,O
160707,6,ID,O
160707,6,consult,O
160707,6,team,O
160707,6,and,O
160707,6,transitioned,O
160707,6,to,O
160707,6,meropenem,B-Drug
160707,6,+,O
160707,6,levofloxacin,B-Drug
160707,6,+,O
160707,6,voriconazole,B-Drug
160707,6,.,O
160707,6,He,O
160707,6,was,O
160707,6,intubated,O
160707,6,electively,O
160707,6,for,O
160707,6,multiple,O
160707,6,procedures,O
160707,6,including,O
160707,6,MRI,O
160707,6,",",O
160707,6,VP,O
160707,6,shunt,O
160707,6,tap,O
160707,6,(,O
160707,6,by,O
160707,6,neurosurgery,O
160707,6,),O
160707,6,",",O
160707,6,and,O
160707,6,bronchoscopy,O
160707,6,and,O
160707,6,extubated,O
160707,6,the,O
160707,6,following,O
160707,6,day,O
160707,6,.,O
160707,6,He,O
160707,6,was,O
160707,6,started,O
160707,6,on,O
160707,6,ambisome,B-Drug
160707,6,in,O
160707,6,place,O
160707,6,of,O
160707,6,voriconazole,B-Drug
160707,6,for,O
160707,7,positive,O
160707,7,galactomannan,B-Reason
160707,7,on,O
160707,7,BAL,O
160707,7,(,O
160707,7,presumed,O
160707,7,aspergillosis,O
160707,7,pneumonia,O
160707,7,),O
160707,7,.,O
160707,7,He,O
160707,7,was,O
160707,7,seen,O
160707,7,by,O
160707,7,the,O
160707,7,neprhology,O
160707,7,team,O
160707,7,and,O
160707,7,started,O
160707,7,on,O
160707,7,HD,O
160707,7,for,O
160707,7,presumed,O
160707,7,clofarabine,B-Drug
160707,7,toxicity,O
160707,7,.,O
160707,7,Mental,O
160707,7,status,O
160707,7,improved,O
160707,7,and,O
160707,7,he,O
160707,7,was,O
160707,7,called,O
160707,7,out,O
160707,7,to,O
160707,7,the,O
160707,7,BMT,O
160707,7,service,O
160707,7,.,O
160707,7,However,O
160707,7,",",O
160707,7,two,O
160707,7,days,O
160707,7,later,O
160707,7,he,O
160707,7,was,O
160707,7,at,O
160707,7,dialysis,O
160707,7,when,O
160707,7,he,O
160707,7,developed,O
160707,7,an,O
160707,7,episode,O
160707,7,of,O
160707,7,altered,O
160707,7,mental,O
160707,7,status,O
160707,7,associated,O
160707,7,with,O
160707,7,tachycardia,O
160707,7,",",O
160707,7,hypertension,O
160707,7,and,O
160707,7,hypoxia,O
160707,7,to,O
160707,7,88,O
160707,7,%,O
160707,7,on,O
160707,7,2L,O
160707,7,NC,O
160707,7,.,O
160707,7,His,O
160707,7,respiratory,O
160707,7,status,O
160707,7,continued,O
160707,7,to,O
160707,7,decline,O
160707,7,and,O
160707,7,he,O
160707,7,was,O
160707,7,reintubated,O
160707,7,and,O
160707,7,transferred,O
160707,7,to,O
160707,7,the,O
160707,7,ICU,O
160707,7,.,O
160707,7,In,O
160707,7,addition,O
160707,7,",",O
160707,7,he,O
160707,7,became,O
160707,7,hypotensive,B-Reason
160707,7,requiring,O
160707,7,pressors,B-Drug
160707,7,for,O
160707,7,a,O
160707,7,few,O
160707,7,hours,O
160707,7,;,O
160707,7,pressors,B-Drug
160707,7,were,O
160707,7,eventually,O
160707,7,weaned,O
160707,7,off,O
160707,7,",",O
160707,7,although,O
160707,7,he,O
160707,7,then,O
160707,7,developed,O
160707,7,shock,O
160707,7,liver,O
160707,7,and,O
160707,7,probable,O
160707,7,DIC,O
160707,7,requiring,O
160707,7,multiple,O
160707,7,transfusions,O
160707,7,.,O
160707,7,Due,O
160707,7,to,O
160707,7,electrolyte,O
160707,7,derangements,O
160707,7,CVVH,O
160707,7,was,O
160707,7,started,O
160707,7,as,O
160707,7,well,O
160707,7,.,O
160707,7,His,O
160707,7,abx,B-Drug
160707,7,were,O
160707,7,broadened,O
160707,7,to,O
160707,7,double,O
160707,7,cover,O
160707,7,aspergillus,B-Reason
160707,7,(,O
160707,7,posaconazole,B-Drug
160707,7,+,O
160707,7,ambisome,B-Drug
160707,7,),O
160707,7,",",O
160707,7,vanc,B-Drug
160707,7,was,O
160707,7,changed,O
160707,7,to,O
160707,7,dapto,B-Drug
160707,7,for,O
160707,7,VRE,B-Reason
160707,7,coverage,I-Reason
160707,7,",",O
160707,7,bactrim,B-Drug
160707,7,was,O
160707,7,added,O
160707,7,for,O
160707,7,PCP,B-Reason
160707,7,[,O
160707,7,**Name,O
160707,7,Initial,O
160707,7,(,O
160707,7,PRE,O
160707,7,),O
160707,7,21150**,O
160707,7,],O
160707,7,.,O
160707,7,At,O
160707,7,approximately,O
160707,7,3:12,O
160707,7,AM,O
160707,7,on,O
160707,7,[,O
160707,7,**2165-6-24**,O
160707,7,],O
160707,7,",",O
160707,7,housestaff,O
160707,7,were,O
160707,7,called,O
160707,7,to,O
160707,7,evaluate,O
160707,7,the,O
160707,7,patient,O
160707,7,after,O
160707,7,his,O
160707,7,nurse,O
160707,7,noticed,O
160707,7,his,O
160707,7,A-line,O
160707,7,pressure,O
160707,7,[,O
160707,7,**Location,O
160707,7,(,O
160707,7,un,O
160707,7,),O
160707,7,1131**,O
160707,7,],O
160707,7,dropped,O
160707,7,abruptly,O
160707,7,to,O
160707,7,SBP,O
160707,7,in,O
160707,7,the,O
160707,7,10s-20s,O
160707,7,.,O
160707,7,On,O
160707,7,evaluation,O
160707,7,",",O
160707,7,he,O
160707,7,was,O
160707,7,unresponsive,O
160707,7,and,O
160707,7,did,O
160707,7,not,O
160707,7,have,O
160707,7,palpable,O
160707,7,pulses,O
160707,7,.,O
160707,7,At,O
160707,7,that,O
160707,7,time,O
160707,7,",",O
160707,7,back,O
160707,7,board,O
160707,7,was,O
160707,7,placed,O
160707,7,beneath,O
160707,7,patient,O
160707,7,and,O
160707,7,CPR,O
160707,7,was,O
160707,7,initiated,O
160707,7,.,O
160707,7,Pulseless,O
160707,7,electrical,O
160707,7,activity,O
160707,7,was,O
160707,7,noted,O
160707,7,on,O
160707,7,the,O
160707,7,monitor,O
160707,7,at,O
160707,7,interval,O
160707,7,2-minute,O
160707,7,pulse,O
160707,7,checks,O
160707,7,(,O
160707,7,no,O
160707,7,shockable,O
160707,7,rhythm,O
160707,7,),O
160707,7,.,O
160707,7,He,O
160707,7,received,O
160707,7,epinephrine,B-Drug
160707,7,1,O
160707,7,mg,O
160707,7,IV,O
160707,7,x,O
160707,7,2,O
160707,7,doses,O
160707,7,at,O
160707,7,five,O
160707,7,minutes,O
160707,7,apart,O
160707,7,.,O
160707,7,Housestaff,O
160707,7,notified,O
160707,7,the,O
160707,7,patient,O
160707,7,'s,O
160707,7,wife,O
160707,7,",",O
160707,7,who,O
160707,7,requested,O
160707,7,that,O
160707,7,the,O
160707,7,resuscitation,O
160707,7,be,O
160707,7,stopped,O
160707,7,.,O
160707,7,At,O
160707,7,this,O
160707,7,time,O
160707,7,",",O
160707,7,CPR,O
160707,7,was,O
160707,7,stopped,O
160707,7,and,O
160707,7,he,O
160707,7,did,O
160707,7,not,O
160707,7,receive,O
160707,7,further,O
160707,7,vasopressors,B-Drug
160707,7,.,O
160707,7,He,O
160707,7,did,O
160707,7,not,O
160707,7,regain,O
160707,7,a,O
160707,8,pulse,O
160707,8,.,O
160707,8,The,O
160707,8,monitor,O
160707,8,continued,O
160707,8,to,O
160707,8,show,O
160707,8,pulseless,O
160707,8,electrical,O
160707,8,activity,O
160707,8,for,O
160707,8,several,O
160707,8,minutes,O
160707,8,with,O
160707,8,slowing,O
160707,8,heart,O
160707,8,rate,O
160707,8,until,O
160707,8,asystole,O
160707,8,.,O
160707,8,At,O
160707,8,that,O
160707,8,time,O
160707,8,",",O
160707,8,the,O
160707,8,patient,O
160707,8,was,O
160707,8,examined,O
160707,8,and,O
160707,8,was,O
160707,8,noted,O
160707,8,to,O
160707,8,have,O
160707,8,no,O
160707,8,audible,O
160707,8,breath,O
160707,8,or,O
160707,8,heart,O
160707,8,sounds,O
160707,8,.,O
160707,8,His,O
160707,8,pupils,O
160707,8,were,O
160707,8,fixed,O
160707,8,and,O
160707,8,dilated,O
160707,8,to,O
160707,8,~5mm,O
160707,8,.,O
160707,8,There,O
160707,8,were,O
160707,8,not,O
160707,8,signs,O
160707,8,of,O
160707,8,life,O
160707,8,evident,O
160707,8,.,O
160707,8,The,O
160707,8,time,O
160707,8,of,O
160707,8,death,O
160707,8,was,O
160707,8,noted,O
160707,8,to,O
160707,8,be,O
160707,8,3:23,O
160707,8,AM,O
160707,8,.,O
160707,8,Attending,O
160707,8,physician,O
160707,8,[,O
160707,8,**Last,O
160707,8,Name,O
160707,8,(,O
160707,8,NamePattern4,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,.,O
160707,8,[,O
160707,8,**First,O
160707,8,Name,O
160707,8,(,O
160707,8,STitle,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,was,O
160707,8,notified,O
160707,8,of,O
160707,8,the,O
160707,8,above,O
160707,8,events,O
160707,8,.,O
160707,8,The,O
160707,8,patient,O
160707,8,'s,O
160707,8,wife,O
160707,8,was,O
160707,8,then,O
160707,8,contact,O
160707,8,[,O
160707,8,**Name,O
160707,8,(,O
160707,8,NI,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,regarding,O
160707,8,an,O
160707,8,autopsy,O
160707,8,and,O
160707,8,agreed,O
160707,8,to,O
160707,8,autopsy,O
160707,8,.,O
160707,8,#,O
160707,8,Access,O
160707,8,:,O
160707,8,portacath,O
160707,8,",",O
160707,8,subclavian,O
160707,8,CVL,O
160707,8,#,O
160707,8,Communication,O
160707,8,:,O
160707,8,Patient,O
160707,8,",",O
160707,8,Wife,O
160707,8,[,O
160707,8,**Name,O
160707,8,(,O
160707,8,NI,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,[,O
160707,8,**Name,O
160707,8,(,O
160707,8,NI,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,[,O
160707,8,**Telephone/Fax,O
160707,8,(,O
160707,8,1,O
160707,8,),O
160707,8,30638**,O
160707,8,],O
160707,8,and,O
160707,8,daughter,O
160707,8,[,O
160707,8,**Name,O
160707,8,(,O
160707,8,NI,O
160707,8,),O
160707,8,**,O
160707,8,],O
160707,8,#,O
160707,8,[,O
160707,8,**Name2,O
160707,8,(,O
160707,8,NI,O
160707,8,),O
160707,8,7092**,O
160707,8,],O
160707,8,:,O
160707,8,FULL,O
160707,8,CODE,O
160707,8,Medications,O
160707,8,on,O
160707,8,Admission,O
160707,8,:,O
160707,8,BISOPROLOL,B-Drug
160707,8,FUMARATE,I-Drug
160707,8,-,O
160707,8,10,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,[,O
160707,8,**Hospital1,O
160707,8,**,O
160707,8,],O
160707,8,ESOMEPRAZOLE,B-Drug
160707,8,MAGNESIUM,I-Drug
160707,8,[,I-Drug
160707,8,NEXIUM,I-Drug
160707,8,],I-Drug
160707,8,-,O
160707,8,40,O
160707,8,mg,O
160707,8,Capsule,O
160707,8,daily,O
160707,8,FOLIC,B-Drug
160707,8,ACID,I-Drug
160707,8,-,O
160707,8,1,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,-,O
160707,8,1,O
160707,8,Tablet,O
160707,8,(,O
160707,8,s,O
160707,8,),O
160707,8,by,O
160707,8,mouth,O
160707,8,once,O
160707,8,a,O
160707,8,day,O
160707,8,INSULIN,B-Drug
160707,8,GLARGINE,I-Drug
160707,8,[,I-Drug
160707,8,LANTUS,I-Drug
160707,8,],I-Drug
160707,8,-,O
160707,8,100,O
160707,8,unit/mL,O
160707,8,Solution,O
160707,8,-,O
160707,8,28,O
160707,8,units,O
160707,8,Solution,O
160707,8,(,O
160707,8,s,O
160707,8,),O
160707,8,at,O
160707,8,bedtime,O
160707,8,INSULIN,B-Drug
160707,8,LISPRO,I-Drug
160707,8,[,I-Drug
160707,8,HUMALOG,I-Drug
160707,8,],I-Drug
160707,8,-,O
160707,8,100,O
160707,8,unit/mL,O
160707,8,Sliding,O
160707,8,scale,O
160707,8,ISOSORBIDE,B-Drug
160707,8,DINITRATE,I-Drug
160707,8,-,O
160707,8,40mg,O
160707,8,TID,O
160707,8,LISINOPRIL,B-Drug
160707,8,-,O
160707,8,20,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,NITROGLYCERIN,B-Drug
160707,8,-,O
160707,8,0.4,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,",",O
160707,8,Sublingual,O
160707,8,PRN,O
160707,8,chest,B-Reason
160707,8,pain,I-Reason
160707,8,OXYBUTYNIN,O
160707,8,CHLORIDE,O
160707,8,5,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,-,O
160707,8,1,O
160707,8,Tablet,O
160707,8,(,O
160707,8,s,O
160707,8,),O
160707,8,by,O
160707,8,mouth,O
160707,8,HS,O
160707,8,(,O
160707,8,at,O
160707,8,bedtime,O
160707,8,),O
160707,8,PRAVASTATIN,B-Drug
160707,8,-,O
160707,8,40,O
160707,8,mg,O
160707,8,Tablet,O
160707,8,QPM,O
160707,8,TAMSULOSIN,B-Drug
160707,8,[,I-Drug
160707,8,FLOMAX,I-Drug
160707,8,],I-Drug
160707,8,-,O
160707,8,0.4,O
160707,8,mg,O
160707,8,daily,O
160707,8,.,O
160707,8,Medications,B-Drug
160707,8,-,O
160707,8,OTC,O
160707,8,CHOLECALCIFEROL,B-Drug
160707,8,(,I-Drug
160707,8,VITAMIN,I-Drug
160707,8,D3,I-Drug
160707,8,),I-Drug
160707,9,[,I-Drug
160707,9,VITAMIN,I-Drug
160707,9,D-3,I-Drug
160707,9,],I-Drug
160707,9,400,O
160707,9,unit,O
160707,9,Tablet,O
160707,9,Daily,O
160707,9,CYANOCOBALAMIN,B-Drug
160707,9,(,I-Drug
160707,9,VITAMIN,I-Drug
160707,9,B-12,I-Drug
160707,9,),I-Drug
160707,9,"1,000",O
160707,9,mcg,O
160707,9,Tablet,O
160707,9,daily,O
160707,9,MULTIVITAMIN,B-Drug
160707,9,-,O
160707,9,1,O
160707,9,Tablet,O
160707,9,PYRIDOXINE,B-Drug
160707,9,-,O
160707,9,100,O
160707,9,mg,O
160707,9,daily,O
160707,9,Zyrtec,B-Drug
160707,9,1,O
160707,9,tab,O
160707,9,daily,O
160707,9,Discharge,O
160707,9,Medications,O
160707,9,:,O
160707,9,Expired,O
160707,9,Discharge,O
160707,9,Disposition,O
160707,9,:,O
160707,9,Expired,O
160707,9,Discharge,O
160707,9,Diagnosis,O
160707,9,:,O
160707,9,Expired,O
160707,9,Discharge,O
160707,9,Condition,O
160707,9,:,O
160707,9,Expired,O
160707,9,Discharge,O
160707,9,Instructions,O
160707,9,:,O
160707,9,Expired,O
160707,9,Followup,O
160707,9,Instructions,O
160707,9,:,O
160707,9,Expired,O
160707,9,Completed,O
160707,9,by,O
160707,9,:,O
160707,9,[,O
160707,9,**2165-6-25**,O
160707,9,],O
